Adjuvant!^© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

By Paridaens Robert   Gelber Shari   Cole Bernard   Gelber Richard   Thürlimann Beat   Price Karen   Holmberg Stig   Crivellari Diana   Coates Alan   Goldhirsch Aron  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Behaviour of metastasis in relation to vascular index in patients with node-positive breast cancer treated with adjuvant tamoxifen

By Gasparini Giampietro   Fanelli Massimo   Boracchi Patrizia   Morabito Alessandro   Locopo Nathalia   Biganzoli Elia  

Clinical and Experimental Metastasis, Vol. 18, Iss. 1, 2000-01 ,pp. : 15-20

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer

By Ananda Sumitra   Steer Christopher  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 109-111

Informa Healthcare

Access to resources Recommend Favorite

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer

By Masuda Norikazu   Iwata Hiraji   Rai Yoshiaki   Anan Keisei   Takeuchi Toru   Kohno Norio   Takei Hiroyuki   Yanagita Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 443-451

Springer Publishing Company

Access to resources Recommend Favorite